These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2229 related items for PubMed ID: 25406852

  • 1. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM, Cerroni L.
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [Abstract] [Full Text] [Related]

  • 2. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
    LeBlanc RE, Lefterova MI, Suarez CJ, Tavallaee M, Kim YH, Schrijver I, Kim J, Gratzinger D.
    Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
    [Abstract] [Full Text] [Related]

  • 3. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J, Schmid K, Trautinger F, Wallnöfer W, Muellauer L, Soleiman A, Knobler R, Haitel A, Pehamberger H, Raderer M.
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [Abstract] [Full Text] [Related]

  • 4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [Abstract] [Full Text] [Related]

  • 5. Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.
    Meyerson HJ, Awadallah A, Pavlidakey P, Cooper K, Honda K, Miedler J.
    Mod Pathol; 2013 Jan; 26(1):32-43. PubMed ID: 22918164
    [Abstract] [Full Text] [Related]

  • 6. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
    Wang L, Rocas D, Dalle S, Sako N, Pelletier L, Martin N, Dupuy A, Tazi N, Balme B, Vergier B, Beylot-Barry M, Carlotti A, Bagot M, Battistella M, Chaby G, Ingen-Housz-Oro S, Gaulard P, Ortonne N.
    Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
    [Abstract] [Full Text] [Related]

  • 7. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
    Cetinözman F, Jansen PM, Willemze R.
    Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
    [Abstract] [Full Text] [Related]

  • 8. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM, Dyrsen ME.
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [Abstract] [Full Text] [Related]

  • 9. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R.
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [Abstract] [Full Text] [Related]

  • 10. TOX expression in different subtypes of cutaneous lymphoma.
    Morimura S, Sugaya M, Suga H, Miyagaki T, Ohmatsu H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S.
    Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
    [Abstract] [Full Text] [Related]

  • 11. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH, Tensen CP, van der Stoop PM, van Oostveen HW, Lund M, Scheper RJ, Willemze R.
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [Abstract] [Full Text] [Related]

  • 12. Expression of follicular helper T-cell markers in primary cutaneous T-cell lymphoma.
    Park JH, Han JH, Kang HY, Lee ES, Kim YC.
    Am J Dermatopathol; 2014 Jun; 36(6):465-70. PubMed ID: 24162385
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
    Santucci M, Pimpinelli N, Massi D, Kadin ME, Meijer CJ, Müller-Hermelink HK, Paulli M, Wechsler J, Willemze R, Audring H, Bernengo MG, Cerroni L, Chimenti S, Chott A, Díaz-Pérez JL, Dippel E, Duncan LM, Feller AC, Geerts ML, Hallermann C, Kempf W, Russell-Jones R, Sander C, Berti E, EORTC Cutaneous Lymphoma Task Force.
    Cancer; 2003 Feb 01; 97(3):610-27. PubMed ID: 12548603
    [Abstract] [Full Text] [Related]

  • 14. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E, Economidou J, Psarra A, Kapsimali V, Mantzana V, Antoniou C, Limas K, Stratigos A, Stavrianeas N, Avgerinou G, Katsambas A.
    Br J Dermatol; 2003 Apr 01; 148(4):709-18. PubMed ID: 12752128
    [Abstract] [Full Text] [Related]

  • 15. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.
    Stoll JR, Willner J, Oh Y, Pulitzer M, Moskowitz A, Horwitz S, Myskowski P, Noor SJ.
    J Am Acad Dermatol; 2021 Nov 01; 85(5):1073-1090. PubMed ID: 33940098
    [Abstract] [Full Text] [Related]

  • 16.
    Schukow C, Ahmed A.
    ; 2024 01 01. PubMed ID: 36944007
    [Abstract] [Full Text] [Related]

  • 17. TCR-γ expression in primary cutaneous T-cell lymphomas.
    Rodríguez-Pinilla SM, Ortiz-Romero PL, Monsalvez V, Tomás IE, Almagro M, Sevilla A, Camacho G, Longo MI, Pulpillo Á, Diaz-Pérez JA, Montes-Moreno S, Castro Y, Echevarría B, Trébol I, Gonzalez C, Sánchez L, Otín AP, Requena L, Rodríguez-Peralto JL, Cerroni L, Piris MÁ.
    Am J Surg Pathol; 2013 Mar 01; 37(3):375-84. PubMed ID: 23348211
    [Abstract] [Full Text] [Related]

  • 18. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Jarrousse V, Quereux G, Marques-Briand S, Knol AC, Khammari A, Dreno B.
    Eur J Dermatol; 2006 Mar 01; 16(6):636-41. PubMed ID: 17229603
    [Abstract] [Full Text] [Related]

  • 19. The pathology of cutaneous T-cell lymphoma.
    Robson A.
    Oncology (Williston Park); 2007 Feb 01; 21(2 Suppl 1):9-12. PubMed ID: 17474353
    [Abstract] [Full Text] [Related]

  • 20. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R, Quaglino P, Novelli M, Fierro MT, Comessatti A, Peroni A, Bonello L, Bernengo MG.
    Br J Dermatol; 2005 Sep 01; 153(3):565-73. PubMed ID: 16120144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 112.